Clinical trials
Phase 2 Colonic Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 5 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GERCOR - Multidisciplinary Oncology Cooperative Group | 4 |
| Leiden University Medical Center | 3 |
| Fudan University | 2 |
| Shanghai Zhongshan Hospital | 2 |
| West China Hospital | 2 |
| Academic and Community Cancer Research United | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Astex Pharmaceuticals, Inc. | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| China Medical University, China | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colonic Neoplasms | 57 |
| Colorectal Neoplasms | 25 |
| Rectal Neoplasms | 20 |
| Stomach Neoplasms | 4 |
| Neoplasm Metastasis | 3 |
| Pancreatic Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
| Neoplasms | 2 |
| Adenocarcinoma, Follicular | 1 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.